JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Higashi, K.
Right arrow Articles by Yamamoto, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Higashi, K.
Right arrow Articles by Yamamoto, I.

18F-FDG Uptake as a Biologic Prognostic Factor for Recurrence in Patients with Surgically Resected Non–Small Cell Lung Cancer

Kotaro Higashi, MD1, Yoshimichi Ueda, MD2, Yukiko Arisaka, MD1, Tsutomu Sakuma, MD3, Yoshihiro Nambu, MD4, Manabu Oguchi, MD1, Hiroyasu Seki, MD5, Suzuka Taki, MD1, Hisao Tonami, MD1 and Itaru Yamamoto, MD1

1 Department of Radiology, Kanazawa Medical University, Ishikawa, Japan
2 Department of Pathology, Kanazawa Medical University, Ishikawa, Japan
3 Department of Respiratory Surgery, Kanazawa Medical University, Ishikawa, Japan
4 Division of Respiratory Disease, Department of Internal Medicine, Kanazawa Medical University, Ishikawa, Japan
5 Department of Radiology, Kanazawa Cardiovascular Hospital, Ishikawa, Japan



View larger version (30K):

[in a new window]
 
FIGURE 1. (A) Kaplan–Meier survival curves of all 57 patients according to SUV of lung cancer. (B) Kaplan–Meier disease-free survival curves of all 57 patients according to SUV of lung cancer. (C and D) Kaplan–Meier disease-free survival curves of 46 patients with pathologic stage (pStage) I NSCLC (C) and 38 patients with pStage IA NSCLC (D) according to SUV of lung cancer. Curves reveal clear demarcation, with poor survival or disease-free survival of subjects in high-SUV group.

 


View larger version (79K):

[in a new window]
 
FIGURE 2. Patient 37: moderately differentiated adenocarcinoma, 3.5 cm in maximal diameter, pathologic stage IB (T2 N0 M0). (A) CT image shows nodule in right lung. (B) 18F-FDG PET shows faint accumulation in tumor (SUV, 2.12). Patient was alive 53 mo after PET study.

 


View larger version (53K):

[in a new window]
 
FIGURE 3. Patient 35: moderately differentiated adenocarcinoma, 2.9 cm in maximal diameter, pathologic stage IA (T1 N0 M0). (A) CT image shows nodule in right lung. (B) 18F-FDG PET shows hot accumulation in tumor (SUV, 5.76). Patient suffered recurrence in brain 27 mo after PET study and died 32 mo after PET study.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.